Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus

Abstract

The crystal structure of a recombinant form of the proteinase encoded by the feline immunodeficiency virus (FIV PR) has been solved at 2 Å resolution and refined to an R-factor of 0.148. The refined structure includes a peptidomimetic, statine-based inhibitor, LP-149, which is an even more potent inhibitor of HIV PR. Kinetic parameters were obtained for the cleavage of five substrates by FIV PR, and inhibition constants were measured for four inhibitors. The structure of FIV PR resembles other related retroviral enzymes although few inhibitors of HIV PR are capable of inhibiting FIV PR. The structure of FIV PR will enhance our knowledge of this class of enzymes, and will direct testing of new proteinase inhibitors in a feline animal model.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Temin, H.M. in The Retroviridae (ed. Levy, J.A.) 1–18 (Plenum Press, New York; 1992).

    Book  Google Scholar 

  2. Fauci, A.S. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 239, 617–622 (1988).

    Article  CAS  PubMed  Google Scholar 

  3. Jaskólski, M., Miller, M., Rao, J.K.M., Leis, J. & Wlodawer, A. Structure of the aspartic proteinase from Rous Sarcoma retrovirus refined at 2-Å resolution. Biochem. 29, 5889–5898 (1990).

    Article  Google Scholar 

  4. Wlodawer, A. et al. Conserved folding in retroviral proteinases: Crystal structure of a synthetic HIV-1 proteinase. Science 245, 616–621 (1989).

    Article  CAS  PubMed  Google Scholar 

  5. Miller, M. et al. Structure of complex of synthetic HIV-1 proteinase with a substrate-based inhibitor at 2.3 Å resolution. Science 246, 1149–1152 (1989).

    Article  CAS  PubMed  Google Scholar 

  6. Wlodawer, A. & Erickson, J.W. Structure-based inhibitors of HIV-1 proteinase. A. Rev. Biochem. 62, 543–585 (1993).

    Article  CAS  Google Scholar 

  7. Appelt, K. Crystal structures of HIV-1 proteinase-inhibitor complexes. Persp. in drug Discov. Design 1, 23–48 (1993).

    Article  CAS  Google Scholar 

  8. Mulichak, A.M. et al. The crystallographic structure of the proteinase from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors. J. biol. Chem. 268, 13103–13109 (1993).

    CAS  PubMed  Google Scholar 

  9. Tong, L., Pav, S., Pargellis, C., Do, F., Lamarre, D. & Anderson, P.C. Crystal structure of human immunodeficiency virus (HIV) type 2 proteinase in complex with a reduced amide inhibitor and comparison with HIV-1 proteinase structures. Proc. natn. Acad. Sci. U.S.A. 90, 8387–8391 (1993).

    Article  CAS  Google Scholar 

  10. Zhao, B., Winborne, E., Minnich, M.D., Culp, J.S., Debouck, C. & Abdel-Meguid, S.S. Three-dimensional structure of a simian immunodeficiency virus proteinase/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 proteinase inhibitors. Biochemistry 32, 13054–13060 (1993).

    Article  CAS  PubMed  Google Scholar 

  11. Wilderspin, A.F. & Sugrue, R.J. Alternative native flap conformation revealed by 2.3 Å resolution structure of SIV proteinase. J. molec. Biol. 239, 97–103 (1994).

    Article  CAS  PubMed  Google Scholar 

  12. Pedersen, N.C. in: The Retroviridae (ed. Levy, J.A.) 181–228 (Plenum Press, New York; 1993).

    Book  Google Scholar 

  13. Gardner, M.B. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Antiviral Res. 15, 267–286 (1991).

    Article  CAS  PubMed  Google Scholar 

  14. Farmerie, W.G., Goodenow, M.M. & Dunn, B.M., Cloning, expression and kinetic characterization of the feline immunodeficiency virus proteinase. Adv. exp. med. Biol. 306, 511–513 (1991).

    Article  CAS  PubMed  Google Scholar 

  15. Elder, J.H. et al. Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus. J. Virol. 67, 1869–1876 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Talbott, R.L. et al. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. natn. Acad. Sci. U.S.A. 86, 5743–5747 (1989).

    Article  CAS  Google Scholar 

  17. Gustchina, A. in Aspartic Proteinases (ed. Takahashi, K.) (Plenum Publishing Corporation, New York; 1995).

    Google Scholar 

  18. Lin, Y. et al. Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 proteinase: Relationship to drug resistance. Biochemistry 34, 1143–1152 (1995).

    Article  CAS  PubMed  Google Scholar 

  19. Andreeva, N.S. in Structure and Biosynthesis of Proteins (ed. Makarova, R.F.) 97–114 (Scientific Center for Biological Publishing, Pushchino; 1988).

    Google Scholar 

  20. Harte, W.E., Jr, Swaminathan, S., Mansuri, M.M., Martin, J.C., Rosenberg, I.E. & Beveridge, D.L. Domain communication in the dynamical structure of human immunodeficiency virus proteinase. Proc. natn. Acad. Sci. U.S.A. 87, 8864–8868 (1990).

    Article  CAS  Google Scholar 

  21. Gustchina, A. & Weber, I.T. Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases. Proteins 10, 325–339 (1991).

    Article  CAS  PubMed  Google Scholar 

  22. Sardana, V.V. et al. Human immunodeficiency virus type 1 protease inhibitors: Evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site. Biochemistry 33, 2004–2010 (1994).

    Article  CAS  PubMed  Google Scholar 

  23. Otto, M.J. et al. In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 proteinase. Proc. natn. Acad. Sci. U.S.A. 90, 7543–7547 (1993).

    Article  CAS  Google Scholar 

  24. Ho, D.D. et al. Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric proteinase inhibitor. J. Virol. 68, 2016–2020 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Condra, J.H. et al. In vivo emergence of HIV-1 variants resistant to multiple proteinase inhibitors. Nature 374, 569–571 (1995).

    Article  CAS  PubMed  Google Scholar 

  26. Griffiths, J.T. et al. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic* hydrophobic- or -aromatic* pro- cleavage sites. Biochemistry 31, 5193–5200 (1992).

    Article  CAS  PubMed  Google Scholar 

  27. Gellman, S.H. On the role of methionine residues in the sequence-independent recognition of nonpolar protein surfaces. Biochemistry 30, 6633–6636 (1991).

    Article  CAS  PubMed  Google Scholar 

  28. Thanki, N. et al. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. Prot. Sci. 1, 1061–1072 (1992).

    Article  CAS  Google Scholar 

  29. Hui, K.Y., Hermann, R.B., Manetta, J.V., Gygi, T. & Angleton, E.L. Model peptides to study the effects of P2 and P3 substitutions in statine-containing HIV proteinase inhibitors. FEBS Lett. 327, 355–360 (1993).

    Article  CAS  PubMed  Google Scholar 

  30. Dunn, B.M., Scarborough, P.E., Davenport, R. & Swienicki, W. in: Methods in Molecular Biology (ed. Dunn, B.M. & Pennington, M.W.) 225–243 (Humana Press, Totowa; 1994).

    Google Scholar 

  31. Brunger, A. X-PLOR: A System for X-Ray Crystallography and NMR. (Yale University Press, New Haven; 1992).

    Google Scholar 

  32. Furey, W. & Swaminathan, S. Phases-A program package for the processing and analysis of diffraction data for macromolecules. Ada crystallogr. (1990).

  33. Hendrickson, W.A. Stereochemically restrained refinement of macromolecular structures. Meth. Enzymol. 115, 252–270 (1985).

    Article  CAS  Google Scholar 

  34. Finzel, B.C. Incorporation of fast Fourier transforms to speed restrained least-squares refinement of protein structures. J. appl. Crystallogr. 20, 53–55 (1987).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wlodawer, A., Gustchina, A., Reshetnikova, L. et al. Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus. Nat Struct Mol Biol 2, 480–488 (1995). https://doi.org/10.1038/nsb0695-480

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/nsb0695-480

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing